AlphaQ Advisors LLC Sells 70 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

AlphaQ Advisors LLC lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,323 shares of the medical equipment provider’s stock after selling 70 shares during the quarter. Intuitive Surgical makes up about 3.3% of AlphaQ Advisors LLC’s holdings, making the stock its 10th largest holding. AlphaQ Advisors LLC’s holdings in Intuitive Surgical were worth $1,213,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Bennett Selby Investments LP grew its holdings in Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after buying an additional 17 shares during the last quarter. Onefund LLC lifted its holdings in Intuitive Surgical by 1.9% in the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock valued at $494,000 after purchasing an additional 18 shares in the last quarter. Wesbanco Bank Inc. lifted its stake in shares of Intuitive Surgical by 1.6% during the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after buying an additional 19 shares during the period. Journey Strategic Wealth LLC grew its stake in Intuitive Surgical by 1.9% in the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after acquiring an additional 19 shares during the period. Finally, FSM Wealth Advisors LLC raised its holdings in Intuitive Surgical by 3.7% in the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock valued at $275,000 after acquiring an additional 19 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $557.16 on Wednesday. Intuitive Surgical, Inc. has a fifty-two week low of $396.15 and a fifty-two week high of $616.00. The firm has a fifty day moving average price of $508.11 and a two-hundred day moving average price of $537.36. The firm has a market cap of $199.70 billion, a price-to-earnings ratio of 86.92, a P/E/G ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter in the prior year, the company earned $1.50 EPS. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 8,900 shares of the business’s stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the transaction, the executive vice president now directly owns 5,758 shares in the company, valued at $2,793,033.06. The trade was a 60.72% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Jamie Samath sold 188 shares of the firm’s stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $566.94, for a total value of $106,584.72. Following the completion of the sale, the chief financial officer now owns 7,162 shares of the company’s stock, valued at $4,060,424.28. This represents a 2.56% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 32,700 shares of company stock worth $16,865,621. Insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. Barclays dropped their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a research report on Thursday, April 24th. Piper Sandler cut their price objective on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a report on Wednesday, April 23rd. Bernstein Bank lifted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. JPMorgan Chase & Co. boosted their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Finally, BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the company a “buy” rating in a research report on Monday, April 14th. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $598.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.